- Bachem Holding AG
- Biotage
- Creative Diagnostics
- GenScript
- Lonza
- Merck KGaA
- PolyPeptide Group
- Puresynth Research Chemicals Pvt Ltd.
- Syngene International Limited
- Thermo Fisher Scientific Inc.
1. Expanding Pharmaceutical R&D
Peptides are increasingly favored in drug development due to their high specificity and biocompatibility. As biopharmaceutical research intensifies, peptide synthesis plays a crucial role in developing treatments for cancer, metabolic disorders, and infectious diseases. Pharmaceutical firms and CROs are investing in automated peptide synthesizers and customized peptides, boosting demand for advanced synthesis technologies.
2. Technological Innovations in Solid-Phase Synthesis
Solid-phase peptide synthesis (SPPS) continues to dominate due to its efficiency and scalability. Innovations in resins, reagents, and purification techniques have reduced synthesis time and increased yield. As demand for high-purity peptides grows in diagnostic and therapeutic applications, companies are focusing on automation and miniaturization of synthesis processes to improve throughput and cost-effectiveness.